PerpEquities

Top analysts on stock perps · Analyst

James Quigley (Goldman Sachs): analyst track record on stock perps

James Quigley of Goldman Sachs on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.

Stars0.2★
Success41%
Excess return-7.0%
rank#11,960
Ratings172
ratings on stock perps14

Track record

TipRanks data via FMP
12 months3 years
Ratings47116
Stock2026
Buy / hold / sell23 / 20 / 438 / 53 / 25
Upgrades / downgrades / initiations3 / 3 / 06 / 4 / 5
Price targets hit / missed12 / 34 (26%)53 / 59 (47%)
Avg. return after a rating (TipRanks)-4.0%+7.9%
Best / worst call+43.3% / -35.3%+83.1% / -72.5%

After buy calls: median 21-day move +2.7% · vs S&P 500 +1.0% · targets hit within a year 17% (n = 14)

Current calls on stock perps

StockCallTargetvs last closeDate
$NVO Novo Nordisk A/SHold · Maintained$44.000.0%Aug 6, 2026

Recent ratings

  • Aug 6, 2026 $NVO: Maintained · Hold · $44.00 · article
  • Jun 3, 2026 $NVO: Maintained · Hold · $47.00 · article
  • Mar 3, 2026 $NVO: Downgraded · Hold · $41.00 · article
  • Jan 23, 2026 $NVO: Maintained · Buy · $68.00 · article
  • Nov 28, 2025 $NVO: Maintained · Buy · $54.00 · article
  • Sep 12, 2025 $NVS: Downgraded · Sell · $118 · article
  • Jan 13, 2025 $NVO: Maintained · Buy · $124 · article
  • Aug 8, 2024 $NVO: Maintained · Buy · article
  • Sep 5, 2024 $NVS: Downgraded · Hold · $121 · article
  • Jun 26, 2024 $NVO: Maintained · Buy · $153 · article
  • Jul 19, 2024 $NVO: Maintained · Buy · $160 · article
  • May 30, 2024 $AZN: Initiated · Buy · $204 · article
  • May 30, 2024 $NVS: Initiated · Buy · $120 · article
  • May 30, 2024 $NVO: Initiated · Buy · $156 · article

James Quigley0.2★ · 41% success · -7.0% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.